BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• FDA

  Aralez Receives Health Canada Approval For Blexten

  April 25, 2016

   · 

  7 min read
• Drug Development

  Fibrocell Science, Inc. Receives Orphan Drug Designation From The FDA For FCX-013 For The Treatment Of Localized Scleroderma

  April 25, 2016

   · 

  5 min read
• Aviragen Therapeutics Completes Royalty Deal With Healthcare Royalty Partners For Proceeds Of $20 Million

  April 25, 2016

   · 

  5 min read
• Business

  NewLink Genetics Awarded $21.6 Million Contract Option By BARDA For Ebola Vaccine Development

  April 25, 2016

   · 

  4 min read
• Valeant Receives Additional Notices Of Default Under Indentures Due To Delayed 10-K Filing

  April 25, 2016

   · 

  3 min read
• Drug Development

  Allovate Announces Positive Results Of Proof-Of-Concept Study Of Oral Mucosal Immunotherapy (OMIT)

  April 25, 2016

   · 

  5 min read
• BioCapital

  Jett Foundation Release: Massachusetts Governor Sending Top Aide To Support Duchenne Drug Approval

  April 25, 2016

   · 

  4 min read
• Pharm Country

  Intrommune Therapeutics Announces Positive Results Of Proof-Of-Concept Study Of Oral Mucosal Immunotherapy (OMIT) Platform For The Treatment Of Allergies

  April 25, 2016

   · 

  4 min read
• Pharm Country

  West Pharmaceutical Services Makes Investment In NanoPass

  April 25, 2016

   · 

  3 min read
• Adan Medical Innovation Announces Launch Of Clinical Trial For Anapphylaxis—Its Smart Case And Mobile Phone App For Epinephrine Autoinjectors

  April 25, 2016

   · 

  2 min read